» Articles » PMID: 38302523

The Outcomes of Re-Redo Bariatric Surgery-results from Multicenter Polish Revision Obesity Surgery Study (PROSS)

Overview
Journal Sci Rep
Specialty Science
Date 2024 Feb 1
PMID 38302523
Authors
Affiliations
Soon will be listed here.
Abstract

The increasing prevalence of bariatric surgery has resulted in a rise in the number of redo procedures as well. While redo bariatric surgery has demonstrated its effectiveness, there is still a subset of patients who may not derive any benefits from it. This poses a significant challenge for bariatric surgeons, especially when there is a lack of clear guidelines. The primary objective of this study is to evaluate the outcomes of patients who underwent Re-Redo bariatric surgery. We conducted a retrospective cohort study on a group of 799 patients who underwent redo bariatric surgery between 2010 and 2020. Among these patients, 20 individuals underwent a second elective redo bariatric surgery (Re-Redo) because of weight regain (15 patients) or insufficient weight loss, i.e. < 50% EWL (5 patients). Mean BMI before Re-Redo surgery was 38.8 ± 4.9 kg/m. Mean age was 44.4 ± 11.5 years old. The mean %TWL before and after Re-Redo was 17.4 ± 12.4% and %EBMIL was 51.6 ± 35.9%. 13/20 patients (65%) achieved > 50% EWL. The mean final %TWL was 34.2 ± 11.1% and final %EBMIL was 72.1 ± 20.8%. The mean BMI after treatment was 31.9 ± 5.3 kg/m. Complications occurred in 3 of 20 patients (15%), with no reported mortality or need for another surgical intervention. The mean follow-up after Re-Redo was 35.3 months. Although Re-Redo bariatric surgery is an effective treatment for obesity, it carries a significant risk of complications.

Citing Articles

Setting the Standard: Cumulative Total Weight Loss as Outcome Measure After Secondary Bariatric Metabolic Surgery.

van Dam K, Verkoulen G, de Witte E, Broos P, Greve J, Boerma E Obes Surg. 2024; 34(9):3521-3522.

PMID: 39042308 DOI: 10.1007/s11695-024-07398-9.

References
1.
Chiappetta S, Lainas P, Kassir R, Valizadeh R, Bosco A, Kermansaravi M . Gastroesophageal Reflux Disease as an Indication of Revisional Bariatric Surgery-Indication and Results-a Systematic Review and Metanalysis. Obes Surg. 2022; 32(9):3156-3171. DOI: 10.1007/s11695-022-06183-w. View

2.
Kermansaravi M, Jazi A, Shahmiri S, Eghbali F, Valizadeh R, Rezvani M . Revision procedures after initial Roux-en-Y gastric bypass, treatment of weight regain: a systematic review and meta-analysis. Updates Surg. 2021; 73(2):663-678. DOI: 10.1007/s13304-020-00961-w. View

3.
Nevo N, Abu-Abeid S, Hazzan D, Lahat G, Nachmani I, Eldar S . Gastric Bypass as a Third Bariatric Procedure-Our Experience with 42 Cases. Obes Surg. 2018; 29(1):215-220. DOI: 10.1007/s11695-018-3503-6. View

4.
Altieri M, Wright B, Peredo A, Pryor A . Common weight loss procedures and their complications. Am J Emerg Med. 2018; 36(3):475-479. DOI: 10.1016/j.ajem.2017.11.050. View

5.
Migaczewski M, Czerwinska A, Rubinkiewicz M, Zarzycki P, Pisarska M, Rymarowicz J . The prevalence of, and risk factors for, Barrett's oesophagus after sleeve gastrectomy. Wideochir Inne Tech Maloinwazyjne. 2021; 16(4):710-714. PMC: 8669983. DOI: 10.5114/wiitm.2021.107776. View